Latest Conference Articles

Intensive Telehealth Program Improves A1c In Rural Patients with Type 2 Diabetes

Intensive Telehealth Program Improves A1c In Rural Patients with Type 2 Diabetes

June 15th 2020

ADA

ADA 2020. Improvement in glycemic control among US veterans was seen across 5 study sites and was sustained at 18 months after study initiation, says study reported at the ADA 80th Virtual Scientific Sessions.

Novel Once-weekly Basal Insulin Found Comparable to QD Insulin Glargine

Novel Once-weekly Basal Insulin Found Comparable to QD Insulin Glargine

June 15th 2020

ADA

ADA 2020. An investigational once-weekly insulin proved comparable in safety and efficacy to traditional once-daily insulin glargine in findings presented at the ADA 80th Annual Virtual Scientific Sessions.

Dapagliflozin Reduces Incident T2D in Patients with HFrEF

Dapagliflozin Reduces Incident T2D in Patients with HFrEF

June 15th 2020

ADA

ADA 2020. Dapagliflozin reduced new onset type 2 diabetes in patients with heart failure with reduced ejection fraction, according to a study released today at the ADA 80th Virtual Scientific Sessions.

ADA2020: SGLT-2 Inhibitor Delays Insulin Initiation, Intensification in T2D with CVD

ADA2020: SGLT-2 Inhibitor Delays Insulin Initiation, Intensification in T2D with CVD

June 14th 2020

ADA

ADA2020: Empagliflozin significantly, durably delays need for insulin and for large dose increases, in patients with type 2 diabetes and cardiovascular disease, finds study presented at ADA 80th Scientific Sessions.

ADA: Next Generation “Artificial Pancreas” Improves Glycemic Control, A1c in T1D

ADA: Next Generation “Artificial Pancreas” Improves Glycemic Control, A1c in T1D

June 13th 2020

ADA

ADA 2020: A new automatic insulin delivery system improves glycemic control in young people with type 1 diabetes, according to research presented at the American Diabetes Association Virtual Scientific Sessions.

10 Essential Symposia for Primary Care at ADA 2020

10 Essential Symposia for Primary Care at ADA 2020

June 10th 2020

ADA

The American Diabetes Association kicks off its Virtual 80th Scientific Sessions on Friday, June 12, 2020. Here is our guide to top sessions.

Can Telehealth Bridge Disparities in Access to Pulmonary Rehab?

Can Telehealth Bridge Disparities in Access to Pulmonary Rehab?

May 24th 2019

ATS

DALLAS--In a session at the American Thoracic Society meeting this week study authors reported on gaps in post-discharge care for COPD and on tele-rehabilitation as possible bridge. 

From ATS 2019: Update on Factors that May Help Predict ILD Outcomes

From ATS 2019: Update on Factors that May Help Predict ILD Outcomes

May 23rd 2019

ATS

DALLAS-Studies on 3 factors that may help guide intervention for patients with ILD were presented: factors during mechanical ventilation, WBC count, and weight loss.

ATS Highlights Advances in the Prediction of COPD Outcomes

ATS Highlights Advances in the Prediction of COPD Outcomes

May 23rd 2019

ATS

DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD. 

E-Cigarettes: The New Addiction and Why Physicians Must be Concerned

E-Cigarettes: The New Addiction and Why Physicians Must be Concerned

May 22nd 2019

ATS

DALLAS-At the American Thoracic Society meeting thought leaders cited disturbing trends in e-cigarette use by teens and warned of health dangers, known and unknown.